🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events
NCT07729475Elevated Lipoprotein(a)
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
120
Beijing
2026-07-27
Not yet open
The COMBINE-AF Trial
NCT07633509Atrial Fibrillation (AF), Atrial Fibrillation Catheter Ablation
Yunlong Wang
Not applicable
430
Beijing, Nanjing
2026-07-27
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087Systemic Sclerosis
Boehringer Ingelheim
Phase 3
448
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Luoyang
2026-07-27
Recruiting
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
NCT07585266Gastrointestinal Stromal Neoplasms
GlaxoSmithKline
Phase 3
800
Beijing
2026-07-27
Recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT07492680Solid Tumors
Bristol-Myers Squibb
Phase 2
260
Beijing, Chongqing, Guangzhou, Xinxiang, Shanghai
2026-07-27
Recruiting
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
NCT07760012Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer
Peking University Third Hospital
Not applicable
50
Beijing
2026-07-24
Recruiting
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
NCT07652281Multiple Myeloma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
97
Beijing
2026-07-23
Recruiting
A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma
NCT07661537B-cell Non-Hodgkin Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
90
Beijing, Guangzhou
2026-07-23
Recruiting
Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy
NCT07049692Acute Ischemic Stroke
Beijing Chao Yang Hospital
Not applicable
424
Beijing
2026-07-22
Recruiting
A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes
NCT07668999Tinea Pedis
Sinomune Pharmaceutical Co., Ltd
Phase 1
64
Beijing
2026-07-21
Recruiting
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
NCT07366034Fibrosing Interstitial Lung Disease
Boehringer Ingelheim
Phase 3
35
Beijing, Changsha, Shanghai
2026-07-21
Recruiting
A Phase I Clinical Trial to Evaluate CMS-F021 Following Single and Multiple Doses in Healthy Participants
NCT07790770Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria
Dermavon Holdings Limited
Phase 1
72
Beijing
2026-07-21
Recruiting
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
NCT07512596Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
48
Bengbu, Beijing, Chongqing, Foshan, Guangzhou, Shenzhen, Zhuhai, Shijiazhuang
2026-07-21
Recruiting
A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region
NCT07710664Persistent HPV16 Infection
Newish Biotech (Wuxi) Co., Ltd.
Phase 1
10
Beijing
2026-07-20
Recruiting
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
NCT07596784Generalized Myasthenia Gravis, gMG
Alexion Pharmaceuticals, Inc.
Phase 3
20
Beijing, Changchun, Fuzhou, Jinan, Shanghai, Shijiazhuang, Taiyuan, Tianjin
2026-07-20
Recruiting
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07557420NMOSD, Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Recruiting
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD
NCT07762872Neuromyelitis Optica Spectrum Disorders (NMOSD)
Junwei Hao, MD
Observational
50
Beijing
2026-07-20
Not yet open
A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults
NCT07697846Overweight, Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Beijing
2026-07-18
Not yet open
Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
NCT07713745Neurofibromatosis Type 2, Vestibular Schwannoma, Non-vestibular Schwannoma, Meningioma
Beijing Tiantan Hospital
Phase 2
200
Beijing, Changchun, Shanghai
2026-07-18
Recruiting
Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI.
NCT07749417Acute Kidney Injury
China National Center for Cardiovascular Diseases
Observational
436
Beijing
2026-07-17
Recruiting
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
NCT07725562Parkinson Disease (PD)
Zhejiang Vimgreen Pharmaceuticals, Ltd.
Phase 2/3
152
Beijing
2026-07-17
Recruiting
A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors
NCT07629258Advanced Tumors
Groovy Medicine (Hangzhou) Ltd.
Phase 1
100
Beijing, Langfang, Hangzhou
2026-07-17
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
NCT07640295Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Not yet open
SMP-656 for HER2-Positive Advanced Breast Cancer
NCT07726342HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
Chengdu SciMount Pharmatech Co., Ltd.
Phase 2
60
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Nanjing
2026-07-16
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
NCT07406035Psoriatic Arthritis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
156
Bozhou, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-07-16
Recruiting
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
NCT07720284High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca
Phase 3
915
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou
2026-07-16
Recruiting
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA
NCT07620314Non-Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1
9
Beijing
2026-07-16
Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
NCT07693426Adolescence Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 1
36
Beijing, Wuhan, Shenyang, Jinan
2026-07-16
Not yet open
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
NCT07711678Obstructive Sleep Apnea (OSA), Syndrome, Obstructive Sleep Apnea, Respiration Disorders, Sleep Apnea Syndrome, Obstructive
Beijing Pins Medical Co., Ltd
Not applicable
10
Beijing
2026-07-15
Recruiting
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
NCT07554924Spinal Muscular Atrophy 1
Lanyue Biotech (Hangzhou) Co., Ltd.
Phase 1/2
11
Beijing, Shanghai, Hangzhou
2026-07-15
Not yet open
Bionic Balloon-assisted Delivery Technology on the Labor Process
NCT07707804Vaginal Delivery
Peking Union Medical College Hospital
Not applicable
300
Cangzhou, Beijing
2026-07-15
Recruiting
Implantable Wireless Brain-Computer Interface Systems in Patients With Tetraplegia
NCT07784088Spinal Cord Injury Cervical, Tetraplegia/Tetraparesis, Spinal Cord Injuries (SCI)
BCIFlex Medical Technology Co., Ltd.
Not applicable
34
Beijing
2026-07-15
Not yet open
Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer
NCT07656766Advanced Colorectal Cancer
Peking University People's Hospital
Phase 2
32
Beijing
2026-07-15
Not yet open
Study on the Incremental Predictive Value of Early Resting-State EEG Phenotypes for Functional Prognosis and Risk Stratification in Acute Ischemic Stroke
NCT07741669Stroke
Xuanwu Hospital, Beijing
Observational
5
Beijing
2026-07-15
Not yet open
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
NCT07762547Moyamoya Disease, Moyamoya Syndrome, Aspirin, Remote Ischemic Conditioning
Beijing Tiantan Hospital
Not applicable
724
Beijing
2026-07-15
Not yet open
Development and Validation of a Colorectal Cancer Diagnostic Model
NCT07692555Colorectal Cancer, Advanced Neoplasia, Prediction Models, Risk Stratification
Peking University Cancer Hospital & Institute
Observational
20,000
Beijing, Fuzhou, Xiamen, Yinchuan
2026-07-15
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT07622186Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
150
Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Guilin, Nanning
2026-07-15
Not yet open
Selumetinib for NF2-Related Schwannomatosis
NCT07707947Neurofibromatosis Type 2, NF2, NF2-related Schwannomatosis, Meningioma
Beijing Tiantan Hospital
Phase 2
20
Beijing
2026-07-15
Not yet open
Comparison of Postoperative Functional Outcomes Between Subvastus and Medial Parapatellar Approach in Total Knee Arthroplasty
NCT07742696Osteoarthritis (OA) of the Knee
Peking University Third Hospital
Not applicable
84
Beijing
2026-07-15
Recruiting
Toludesvenlafaxine for Non-specific Low Back Pain
NCT07709416Non-specific Low Back Pain
Beijing Tiantan Hospital
Not applicable
132
Beijing
2026-07-15
Recruiting
Early Identification and Diagnosis of BAD-related Stroke
NCT07693816Branch Atheromatous Disease, Acute Ischemic Stroke, Cerebral Infarction
Peking Union Medical College Hospital
Observational
1,602
Beijing
2026-07-15
Not yet open
A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
NCT07621159Colorectal Cancer Metastatic
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1/2
120
Beijing
2026-07-15
Recruiting
Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT
NCT07677306Myelodysplastic Syndromes
Peking University People's Hospital
Phase 2
120
Beijing
2026-07-15
Recruiting
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
NCT07599410T2DM
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
240
Beijing, Jinan
2026-07-14
Recruiting
Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
NCT06945809Aortic Dissection, Distal Entry Tear
Hangzhou Endonom Medtech Co., Ltd.
Not applicable
216
Beijing
2026-07-13
Not yet open
The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting (MICS-CABG) on the Prevention of Postoperative New-Onset Atrial Fibrillation: A Multicenter, Prospective, Randomized, Triple-Blinded Study
NCT07755072Postoperative Atrial Fibrillation
Peking University Third Hospital
Not applicable
628
Beijing
2026-07-13
Recruiting
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
NCT07424287NMIBC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
236
Beijing, Shanghai
2026-07-13
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NCT07567625Acute Myocardial Infarction (AMI), ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Harbin Medical University
Not applicable
2,000
Harbin, Beijing, Cangzhou, Chengde, Chengdu, Dalian, Daqing, Hunan
2026-07-13
Not yet open
Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial
NCT07678151Hypertension (HTN)
Heart Health Research Center
Not applicable
260
Beijing, Luoyang
2026-07-13
Not yet open
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
NCT07677514Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd.
Phase 2
156
Beijing, Bengbu, Changsha, Chongqing, Fujian, Guangzhou, Hefei, Huizhou
2026-07-12
Not yet open
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD
NCT07658339COPD (Chronic Obstructive Pulmonary Disease)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
387
Beijing
2026-07-11
Recruiting
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
NCT07709520Chronic Hepatitis B
Fujian Akeylink Biotechnology Co., Ltd.
Phase 2
80
Beijing
2026-07-10
Recruiting
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
NCT07684508Hypofractionated Radiotherapy, Intensity-modulated Radiotherapy, Cervical Cancers
Manni Huang
Not applicable
154
Beijing, Langfang
2026-07-10
Not yet open
PulseMagic™ TrueForce™ PAF NMPA Study
NCT07720557Atrial Fibrillation (AF), Paroxysmal AF, Drug Refractory Paroxysmal Atrial Fibrillation, Atrial Arrhythmia
Shanghai MicroPort EP MedTech Co., Ltd.
Not applicable
150
Beijing
2026-07-10
Active, closed
ThromBus Aspiration for Acute Mesenteric Artery Occlusion With Emergent Laparoscopic Surgery
NCT07741318Acute Mesenteric Ischemia
Beijing Tsinghua Chang Gung Hospital
Not applicable
76
Beijing
2026-07-10
Recruiting
Multimodal Ocular Diagnosis-Guided Precision Acupuncture and Lifestyle Intervention for PCOS
NCT07809503Polycystic Ovary Syndrome
Peking University Third Hospital
Not applicable
210
Beijing
2026-07-10
Recruiting
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection
NCT07786779Venous Thromboembolism (VTE)
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 1
40
Beijing
2026-07-10
Recruiting
Efficacy and Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms
NCT07731568Anxiety Symptoms
Beijing HuiLongGuan Hospital
Not applicable
55
Beijing
2026-07-10
Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654Extrapulmonary Neuroendocrine Cancer (epNEC)
Boehringer Ingelheim
Phase 3
390
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2026-07-10
Recruiting
Timing of ctDNA Testing in Advanced Breast Cancer
NCT07681323Advanced Breast Cancer
Geneplus-Beijing Co. Ltd.
Observational
400
Beijing
2026-07-08
Recruiting
A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
NCT07606599Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
398
Hefei, Beijing
2026-07-07
Not yet open
Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)
NCT07535489Moderately to Severely Active Ulcerative Colitis (UC)
Nanjing Immunophage Biotech Co., Ltd
Phase 2
144
Beijing
2026-07-07
Recruiting
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)
NCT07648914Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
446
Beijing
2026-07-06
Not yet open
Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer
NCT07733024Neuroendocrine Tumors
Tingting Yuan
Phase 2
200
Beijing
2026-07-06
Recruiting
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
NCT07586124Head and Neck Squamous Cell Carcinoma
Lepu Biopharma Co., Ltd.
Phase 2
80
Beijing, Fuzhou, Guangzhou, Shantou, Nanning, Shijiazhuang, Wuhan, Changsha
2026-07-06
Recruiting
A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy
NCT07582133Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd.
Phase 2
380
Beijing
2026-07-06
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
NCT07662109Type 2 Diabetes Mellitus
AstraZeneca
Phase 3
2,000
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Chenzhou, Chifeng
2026-07-06
Recruiting
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
NCT07600164HER2 + Breast Cancer, Advanced Breast Cancer
Peking University People's Hospital
Phase 4
500
Beijing
2026-07-06
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
NCT07614152Turner Syndrome
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
84
Anyang, Beijing, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou
2026-07-05
Recruiting
Mindfulness Intervention for Emotional Distress: An EEG Study
NCT07692269Emotional Distress, Anxiety, Depression, Stress (Psychology)
Peking University
Not applicable
160
Beijing
2026-07-04
Recruiting
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
NCT07670416Obesity, Overweight, Type 2 Diabetes Mellitus (T2DM)
Hoffmann-La Roche
Phase 3
300
Zhengzhou, Xianyang, Ningbo, Beijing, Changchun, Hefei, Herbin, Huai'an
2026-07-03
Recruiting
Evaluation of ICP-B208 in Patients With Advanced Solid Tumors
NCT07617493Advanced Solid Tumor
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
539
Beijing
2026-07-03
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
Pfizer
Phase 2
40
Beijing, Fuzhou, Zhengzhou, Wuhan, Nanchang, Shanghai
2026-07-02
Recruiting
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants
NCT07626515Healthy Participants
Hoffmann-La Roche
Phase 1
36
Beijing
2026-07-02
By invitation
Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
NCT07658417Diabetes Mellitus, Type 2
Novo Nordisk A/S
Observational
216
Beijing, Chongqing, Lanzhou, Jiangmen, Langfang, Harbin, Shiyan, Huai'an
2026-07-02
Not yet open
Zishen Yutai Pill for Patients With Recurrent Implantation Failure
NCT07641088Recurrent Implantation Failure
Peking University Third Hospital
Not applicable
878
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Nanjing, Xi'an
2026-07-01
Not yet open
Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation
NCT07426068Metabolic Disease, Amyotrophy
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
Phase EARLY_PHASE1
6
Yancheng, Beijing
2026-07-01
Not yet open
Study of Wenyang Tongbi Formula in the Treatment of Chemotherapy-Induced Polyneuropathy
NCT07626528Chemotherapy-induced Peripheral Neuropathy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
144
Beijing
2026-07-01
Active, closed
Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC
NCT07711470Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
140
Beijing
2026-07-01
Not yet open
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
NCT07575672HFpEF - Heart Failure With Preserved Ejection Fraction, TAVI(Transcatheter Aortic Valve Implantation), Finerenone
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
2,832
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Zhengzhou
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft Fractures
NCT07738380Femoral Shaft Fractures, Femur Fractures, Femur Fracture
Beijing Jishuitan Hospital
Not applicable
80
Beijing
2026-07-01
Recruiting
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
NCT07689851Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Shenzhen, Taiyuan, Beijing
2026-07-01
Not yet open
Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)
NCT07306390Colon Cancer, Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
1,200
Beijing
2026-07-01
Not yet open
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
NCT07596524Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing, Shenzhen, Taiyuan
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Distal Femoral Fractures
NCT07738406Supracondylar Femoral Fractures, Femoral Fractures
Beijing Jishuitan Hospital
Not applicable
80
Beijing
2026-07-01
Recruiting
Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly
NCT07403760Atrial Fibrillation (AF)
Beijing Anzhen Hospital
Not applicable
136
Beijing
2026-07-01
Recruiting
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
NCT07645690Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
Chinese PLA General Hospital
Phase EARLY_PHASE1
30
Beijing
2026-07-01
Recruiting
The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
NCT07095933Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
5
Beijing
2026-07-01
Recruiting
Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis
NCT07639177Rheumatoid Arthritis
Peking Union Medical College Hospital
Phase 2
40
Beijing
2026-07-01
Not yet open
Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma
NCT07612098Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
274
Beijing
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Intertrochanteric Femoral Fractures
NCT07738458Intertrochanteric Fractures, Intertrochanteric Fractures of the Hip, Intertrochanteric Fractures of the Femur
Beijing Jishuitan Hospital
Not applicable
60
Beijing
2026-07-01
Not yet open
Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery
NCT07229495Scoliosis; Adolescence, Pain After Surgery, Analgesia, Patient-controlled
Peking Union Medical College Hospital
Phase 4
171
Zhengzhou, Nanchang, Beijing, Shanghai
2026-07-01
Active, closed
A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa
NCT07727889Hidradenitis Suppurativa (Acne Inversa)
Peking Union Medical College
Phase 2
50
Beijing
2026-07-01
Not yet open
CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors
NCT07657585Advanced Malignant Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
91
Beijing
2026-07-01
Not yet open
Effects of Transcranial Alternating Current Stimulation on Postoperative Anxiety in Patients Undergoing Intraspinal Tumor Resection
NCT07713368Postoperative Anxiety in Patients Undergoing Intraspinal Tumor Resection
Xuanwu Hospital, Beijing
Not applicable
102
Beijing
2026-07-01
Recruiting
The Effect of Exercise-Induced Irisin on Brain Function and Postoperative Delirium in Older Adults
NCT07424170Post Operative Delirium
Peking University People's Hospital
Observational
140
Beijing
2026-07-01
Not yet open
Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis
NCT07650851Chronic Kidney Disease-Associated Pruritus in Hemodialysis
Chinese PLA General Hospital
Not applicable
150
Beijing
2026-07-01
Not yet open
Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).
NCT07684560Chronic Spontaneous Urticaria (CSU), Healthy Volunteers
AlphaMol Science Ltd. (Shanghai)
Phase 1
48
Beijing
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Extra-Articular Distal Tibial Fractures
NCT07733271Distal Tibial Fracture, Tibial Fractures
Beijing Jishuitan Hospital
Not applicable
60
Beijing
2026-07-01
Not yet open
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
NCT07687667Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female
Peking University Third Hospital
Not applicable
406
Beijing
2026-07
Rows per page Showing 301–400 of 5484
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=4

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.